TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 4091238

Group type: EXPERIMENTAL
Intervention: 20 mg methohexital/kg BW
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 25 mg methohexital/kg BW
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 30 mg methohexital/kg BW
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Methohexital plasma levels > 22 micrograms/ml
Number of subjects: 66
Study: 31071355

Group type: EXPERIMENTAL
Intervention: Enlarged food units
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Unit-size increases
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Manipulating perceptual focus on size
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Manipulating perceptual focus on number
Number of subjects: 185
Study: 30006015

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (10 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: APOE ε4 carriers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-ε4 carriers
Number of subjects: 0
Study: 29281208

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS) nursing care
Number of subjects: 200
Study: 24768678

Group type: EXPERIMENTAL
Intervention: 1760 mcg daily fluticasone propionate (FP) for 3 months
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 880 mcg daily fluticasone propionate (FP) after initial CR
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1760 mcg daily fluticasone propionate (FP) for 3 additional months for non-responders
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1760 mcg daily fluticasone propionate (FP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 23364563

Group type: EXPERIMENTAL
Intervention: Toothguide Training (TT) for group A
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Toothguide Training Box (TTB) for group B
Number of subjects: 94

Group type: COMPARATOR
Intervention: Before training for both groups
Number of subjects: 94

Group type: COMPARATOR
Intervention: After training for both groups
Number of subjects: 94
Study: 20225213

Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement
Number of subjects: 112

Group type: COMPARATOR
Intervention: Composite resin
Number of subjects: 112
Study: 17711511

Group type: EXPERIMENTAL
Intervention: TRIMprob
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: TRIMprob combined with DRE findings
Number of subjects: 200
Study: 14622077

Group type: EXPERIMENTAL
Intervention: 16-week treatments for depression
Number of subjects: 30
Study: 10790350

Group type: EXPERIMENTAL
Intervention: Electron-beam CT (EBCT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Coronary angiography
Number of subjects: 112

Group type: COMPARATOR
Intervention: Intracoronary ultrasound (ICUS)
Number of subjects: 112
Study: 8737129

Group type: EXPERIMENTAL
Intervention: Sparfloxacin (200 mg loading dose followed by 100 mg once daily)
Number of subjects: 728

Group type: COMPARATOR
Intervention: Amoxycillin/clavulanic acid (500 mg/125 mg tds)
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Sparfloxacin
Number of subjects: 728

Group type: COMPARATOR
Intervention: Amoxycillin/clavulanic acid
Number of subjects: 728
Study: 1396434

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) monotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Polytherapy (continuation of presurgical polytherapy)
Number of subjects: 40
Study: 3883815

Group type: EXPERIMENTAL
Intervention: Amitriptyline plus perphenazine
Number of subjects: 51

Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 51

Group type: COMPARATOR
Intervention: Perphenazine alone
Number of subjects: 51
Study: 31366683

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: General Anesthesia plus Local Anesthesia (GA + LA)
Number of subjects: 56
Study: 27993489

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention targeting frailty (12-month duration)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 241
Study: 26345362

Group type: EXPERIMENTAL
Intervention: Three sessions of breathing training (hour-long sessions at weekly intervals)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Single session of breathing training (one hour-long session)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Three sessions of breathing training
Number of subjects: 156

Group type: COMPARATOR
Intervention: Single session of breathing training
Number of subjects: 156
Study: 24006873

Group type: EXPERIMENTAL
Intervention: Telephone reminders and information
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Reminder letters and information booklets
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group (no reminders or information)
Number of subjects: 181
Study: 21835220

Group type: EXPERIMENTAL
Intervention: Trivalent FluBlok vaccine (45 mcg of each rHA0 component)
Number of subjects: 4648

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 4648

Group type: EXPERIMENTAL
Intervention: Trivalent FluBlok vaccine
Number of subjects: 4648
Study: 19153079

Group type: EXPERIMENTAL
Intervention: 0.5 h infusion of 0.5 g of imipenem every 6 h for 24 h
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2 h infusion of 0.5 g of imipenem every 6 h for 24 h
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2 h infusion of 1 g of imipenem every 6 h for 24 h
Number of subjects: 9
Study: 17683103

Group type: EXPERIMENTAL
Intervention: Intoxicated arguing couple
Number of subjects: 156

Group type: COMPARATOR
Intervention: Sober arguing couple
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Verbal aggression
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Physical aggression
Number of subjects: 156
Study: 15364356

Group type: EXPERIMENTAL
Intervention: Misoprostol treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 42
Study: 11317490

Group type: EXPERIMENTAL
Intervention: Acute exacerbation of MS (n = 21)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Chronic progressive MS (n = 27)
Number of subjects: 77

Group type: COMPARATOR
Intervention: MS remission (n = 29)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Other neurological diseases (n = 25)
Number of subjects: 77
Study: 8615360

Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol supplementation (1632 mg or 1200 IU/d) for 8 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 1599717

Group type: EXPERIMENTAL
Intervention: Periodic health examination recommendations provided on outpatient charts
Number of subjects: 29

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 29
Study: 6366684

Group type: EXPERIMENTAL
Intervention: Solcoseryl Eye-Gel
Number of subjects: 61

Group type: COMPARATOR
Intervention: 2.4% cysteine eye-gel
Number of subjects: 61
Study: 30616442

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (6 months)
Number of subjects: 12
Study: 29308685

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 150 mg oral pregabalin
Number of subjects: 70
Study: 26727408

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (GCBT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Topical steroid
Number of subjects: 97
Study: 24996379

Group type: EXPERIMENTAL
Intervention: 5.5 Fr sphincterotome group I
Number of subjects: 280

Group type: COMPARATOR
Intervention: 5.5 Fr sphincterotome group II
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Overall cannulation success including precut for failed cases in group I
Number of subjects: 280

Group type: COMPARATOR
Intervention: Overall cannulation success including precut for failed cases in group II
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Crossover and double GW techniques
Number of subjects: 280
Study: 22021072

Group type: COMPARATOR
Intervention: Selective digestive decontamination (SDD)
Number of subjects: 5927

Group type: COMPARATOR
Intervention: Selective oropharyngeal decontamination (SOD)
Number of subjects: 5927

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 5927
Study: 20863994

Group type: EXPERIMENTAL
Intervention: Sevelamer
Number of subjects: 100

Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 100
Study: 18484600

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR; n=15)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Eight Point Program (EPP; n=14)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Waitlist control (n=15)
Number of subjects: 44
Study: 15998659

Group type: EXPERIMENTAL
Intervention: FAT infusion (long-chain triglyceride emulsion, 2.8 kcal/min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: FAT‐THL (120 mg tetrahydrolipstatin, lipase inhibitor)
Number of subjects: 16
Study: 12527979

Group type: EXPERIMENTAL
Intervention: 75 g of glucose ingested 45 min prior to exercise
Number of subjects: 8
Study: 10656432

Group type: EXPERIMENTAL
Intervention: Melphalan 20 mg/m2 (n = 5)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Melphalan 30 mg/m2 (n = 7)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Melphalan 40 mg/m2 (n = 6)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Melphalan (all doses)
Number of subjects: 21
Study: 8882244

Group type: EXPERIMENTAL
Intervention: Fentanyl 5.0 micrograms.kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl 0.625 micrograms.kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 60
Study: 1993621

Group type: EXPERIMENTAL
Intervention: Prolonged treatment elapsed days (14 days beyond the protocol prescription)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Revised criteria for unacceptable overall treatment including prolonged elapsed treatment days
Number of subjects: 426
Study: 31600424

Group type: EXPERIMENTAL
Intervention: Family-based lifestyle intervention (details on dosage and duration not available)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Qualitative feedback on intervention prototypes
Number of subjects: 46
Study: 30934066

Group type: EXPERIMENTAL
Intervention: Rituximab (500 mg/m2, 2 infusions 2 weeks apart, followed by 4 maintenance infusions of 500 mg at 3, 6, 9, and 12 months)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 151
Study: 28671088

Group type: EXPERIMENTAL
Intervention: Mycoplasma pneumoniae infection
Number of subjects: 0
Study: 25537254

Group type: EXPERIMENTAL
Intervention: Movement restriction (wearing a sling)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (not wearing a sling)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Movement restriction
Number of subjects: 40
Study: 23620150

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injections (ITDI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study: 21859417

Group type: EXPERIMENTAL
Intervention: chronoFLO4
Number of subjects: 556

Group type: COMPARATOR
Intervention: FOLFOX2
Number of subjects: 556
Study: 19959960

Group type: EXPERIMENTAL
Intervention: Botox (300 U)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prosigne (300 U)
Number of subjects: 24
Study: 17425756

Group type: EXPERIMENTAL
Intervention: Prednisone dosage higher than 20 mg/d
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Steroids administration
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Steroids therapy
Number of subjects: 25
Study: 16390019

Group type: EXPERIMENTAL
Intervention: Gated perfusion SPECT (GPS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Radionuclide ventriculography (RVG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of EF difference between RVG and GPS
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cold defect number (CDN)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cold perfusion defects (CD%) and infarcted segments (IS%)
Number of subjects: 36
Study: 12471401

Group type: EXPERIMENTAL
Intervention: Aerosolized measles vaccine (Edmonston-Zagreb)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Aerosolized measles-rubella vaccine (Edmonston-Zagreb with RA27/3)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Injected measles vaccine (Edmonston-Zagreb)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Injected measles-rubella vaccine (Edmonston-Zagreb with RA27/3)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Injected Schwarz measles vaccine
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Aerosolized measles vaccine (1000 plaque-forming units of Edmonston-Zagreb)
Number of subjects: 5
Study: 9579001

Group type: COMPARATOR
Intervention: High/Scope Perry Preschool study participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-quality early education programs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Highly intensive academic program participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Investment in educational intervention
Number of subjects: 0
Study: 9345396

Group type: EXPERIMENTAL
Intervention: rIFN-alpha (9 MIU, intramuscularly every other day for 6 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2713577

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 0
Study: 329085

Group type: EXPERIMENTAL
Intervention: Propranolol (80 to 120 mg per day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31280058

Group type: EXPERIMENTAL
Intervention: Encoding immediately after acute stress
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Encoding two hours after acute stress
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (encoding without stress)
Number of subjects: 100
Study: 28254205

Group type: EXPERIMENTAL
Intervention: Family delivered intervention including orientation or memory clues, sensory checks, and cognitive stimulation
Number of subjects: 61
Study: 26232903

Group type: EXPERIMENTAL
Intervention: Telephone intervention (four calls for A1c >7%-9%, eight calls for A1c >9%)
Number of subjects: 941

Group type: COMPARATOR
Intervention: Print-only intervention
Number of subjects: 941

Group type: COMPARATOR
Intervention: Both groups (telephone and print-only)
Number of subjects: 941
Study: 23063337

Group type: EXPERIMENTAL
Intervention: Etonogestrel implant
Number of subjects: 2008

Group type: EXPERIMENTAL
Intervention: Levonorgestrel implant
Number of subjects: 2008

Group type: COMPARATOR
Intervention: Copper IUD (TCu380A)
Number of subjects: 2008
Study: 22263337

Group type: EXPERIMENTAL
Intervention: Desensitizer gel (DG; 5% potassium nitrate and 2% sodium fluoride) applied for 10 minutes before bleaching treatment with 16% carbamide peroxide (CP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo gel applied for 10 minutes before bleaching treatment with 16% carbamide peroxide (CP)
Number of subjects: 60
Study: 19805679

Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 2616
Study: 16384850

Group type: EXPERIMENTAL
Intervention: Recombinant human TSH (rhTSH) preparation with 3.7 GBq (100 mCi) 131I in euthyroid patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional remnant ablation in hypothyroid state with 3.7 GBq (100 mCi) 131I
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Quality of life in euthyroid group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Radiation dose to blood in euthyroid group
Number of subjects: 45
Study: 15015442

Group type: EXPERIMENTAL
Intervention: Kebimin decoction (KD), given one dose per day for 10 days, with 1-3 courses given successively.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Xinfang Rhinitis capsule, treated for 30 days.
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Kebimin decoction (KD)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (Xinfang Rhinitis capsule)
Number of subjects: 82
Study: 11038993

Group type: EXPERIMENTAL
Intervention: Tong Xin Luo (TXL) capsule
Number of subjects: 36

Group type: COMPARATOR
Intervention: Isosorbide dinitrate
Number of subjects: 36
Study: 9210889

Group type: EXPERIMENTAL
Intervention: CDDP-based chemotherapy (CTX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CPT-11 with mitomycin-C regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: CDDP-based regimen
Number of subjects: 0
Study: 8454142

Group type: EXPERIMENTAL
Intervention: Nurses performing sigmoidoscopy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Resident physicians performing sigmoidoscopy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nurses and resident physicians
Number of subjects: 10
Study: 3766171

Group type: COMPARATOR
Intervention: Thermoneutral conditions (25 degrees C)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hot dry environment (40 degrees C)
Number of subjects: 8
Study: 29464379

Group type: EXPERIMENTAL
Intervention: PR-fampridine
Number of subjects: 32
Study: 27996108

Group type: EXPERIMENTAL
Intervention: Use of hormonal contraceptives
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Age at menarche of 13 and older
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Last pregnancy after age 35
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Reproductive period
Number of subjects: 830
Study: 25093539

Group type: EXPERIMENTAL
Intervention: Any type of intervention (different forms of feedback)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Parents' driving behavior
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Perception of parents' commitment to safety
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Parental monitoring
Number of subjects: 166
Study: 22451470

Group type: EXPERIMENTAL
Intervention: Factor 2 (CRP, IL‐1ra, IL‐6)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Waist circumference
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Total and abdominal adiposity
Number of subjects: 179
Study: 19581118

Group type: EXPERIMENTAL
Intervention: DAC-7 (daunorubicin, cytarabine, and cladribine)
Number of subjects: 309

Group type: COMPARATOR
Intervention: DA-7 (daunorubicin and cytarabine)
Number of subjects: 309
Study: 18828769

Group type: EXPERIMENTAL
Intervention: Basiliximab and belatacept therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belatacept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: CNI (Calcineurin Inhibitor)
Number of subjects: 0
Study: 16583932

Group type: EXPERIMENTAL
Intervention: Policosanol 10 mg capsules once daily with the evening meal for 8 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo capsules once daily with the evening meal for 8 weeks
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Policosanol
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 12362101

Group type: EXPERIMENTAL
Intervention: Valdecoxib 10 mg q.d.
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Valdecoxib 20 mg q.d.
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Ibuprofen 800 mg t.i.d.
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Diclofenac 75 mg b.i.d.
Number of subjects: 1052
Study: 9925903

Group type: EXPERIMENTAL
Intervention: Repeated doses of sucrose (0.05 ml of 24% sucrose solution administered three times)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Single dose of sucrose (0.05 ml of 24% sucrose solution for the first dose)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (sterile water administered three times)
Number of subjects: 48
Study: 7559180

Group type: EXPERIMENTAL
Intervention: Tone bursts of 250 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tone bursts of 4000 Hz
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tone bursts of 250 Hz and 4000 Hz
Number of subjects: 0
Study: 2107117

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6988173

Group type: EXPERIMENTAL
Intervention: Oral clenbuterol at 20 to 30 micrograms 3-times daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oral terbutaline at 2.5 to 5 mg 3-times daily
Number of subjects: 16
Study: 28251804

Group type: EXPERIMENTAL
Intervention: Daily micronutrient-rich snack containing green leafy vegetables, fruit, and milk
Number of subjects: 6513

Group type: COMPARATOR
Intervention: Snack made from lower-micronutrient vegetables
Number of subjects: 6513

Group type: EXPERIMENTAL
Intervention: Daily micronutrient-rich snack
Number of subjects: 6513
Study: 26394649

Group type: EXPERIMENTAL
Intervention: Caffeine anhydrous (CAF) 300 mg flat dose (3-5 mg/kg bodyweight)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Coffee (COF) 8.9 g (303 mg caffeine)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (PLA) 3.8 g non-caloric flavouring
Number of subjects: 54
Study: 23676636

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months for 1 year (TP1)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Denosumab (after alendronate)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Higher TP2 baseline necessity scores
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Higher concerns about medication scores
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Higher NCD scores
Number of subjects: 250
Study: 22465268

Group type: EXPERIMENTAL
Intervention: Zoledronate 5 mg
Number of subjects: 50
Study: 20035910

Group type: EXPERIMENTAL
Intervention: Eszopiclone 3 mg orally
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 17099306

Group type: EXPERIMENTAL
Intervention: Amuchina 10% (ExSept Plus) for exit-site care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amuchina 5% (ExSept) for exit-site care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Povidone-iodine for exit-site care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorhexidine for exit-site care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electrolytic chloroxidizing solutions (Amuchina 10% and Amuchina 5%) for exit-site care
Number of subjects: 0
Study: 16158445

Group type: EXPERIMENTAL
Intervention: 50 mg caffeine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 100 mg caffeine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48